FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental ANDA for a generic fixed-dose combination of olmesartan medoxomil, amlodipine, and hydrochlorothiazide for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Olmesartan medoxomil amlodipine and hydrochlorothiazide (olmesartan medoxomil; amlodipine; hydrochlorothiazide)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE)